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Abstract
Drawing on lessons learned from community experiences in concentrated epidemics, this paper
explores three imperatives in the effort to reduce the sexual transmission of HIV: combat
prevention fatigue, diversify HIV testing and combat stigma and discrimination. The paper argues
for a non-judgmental harm reduction approach to the prevention of sexual transmission of HIV that
takes into account the interpretation of risk by diverse individuals and communities in the era of
antiretroviral therapy. This approach requires greater attention to increasing access to
opportunities to know one's serostatus, especially among key populations at greater risk. Novel
approaches to diversifying HIV testing approaches at community level are needed. Finally, the paper
makes a plea for bold measures to combat stigma and discrimination, which continues to represent
a formidable barrier for access to services for affected populations and may contribute to HIV-
related risk behaviours. A "triple therapy" approach to address stigma and discrimination is
discussed, which includes greater acceptance of people living with HIV and AIDS (PLWHA),
improving relevant laws and policies, and involving prevention users- working with people rather than
for people-.
Note: this paper corresponds to the plenary talk of Bruno Spire at the XVIIth World AIDS
Conference, August 8th, Mexico city: http://www.kaisernetwork.org/health_cast/
player.cfm?id=4383
Although about 20 antiretroviral medications have now
been approved for treating people living with HIV and
AIDS (PLWHA), only a limited number of proven HIV
prevention tools and interventions are available, while
others are still at the research stage [1]. An example of a
newly proven intervention to reduce HIV risk is male cir-
cumcision [2]. Male circumcision, however, will not fulfil
all prevention needs [3]. The challenge is to scale-up com-
prehensive HIV prevention programmes based on all
approaches that are known to work. For instance, there is
abundant evidence that harm reduction, which includes
needle syringe programming and access to opioid substi-
tution therapy, reduces HIV transmission among injecting
drug users [4,5]. It is also known that interventions pro-
moting safer sex, in particular through condom use, can
reduce sexual transmission of HIV [6].
However, a narrowly conceived "ABC" strategy has limita-
tions. Abstinence-only programs do not work [7], and a
more comprehensive and balanced approach is required
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that addresses different life stages and situations. There is
evidence that comprehensive behavioural interventions
can result in delayed entry into sexual life and reduced
HIV incidence among young people [8]. Interventions
promoting partner reduction, or discouraging concur-
rency among those who are sexually active, are crucial
although they have had limited success among key popu-
lations at highest risk in most settings [9]. Finally, consist-
ent and correct use of condoms reduces HIV transmission,
but is not sufficient to meet everyone's needs [10]. The
reality is that lifelong consistent condom use is not accept-
able or feasible for most people.
This paper considers lessons learned from community
experiences in concentrated epidemics that should serve
to improve HIV prevention programming, using tools and
interventions that are currently available. It also explores
three imperatives in the effort to reduce the sexual trans-
mission of HIV: combat prevention fatigue, diversify HIV
testing and combat stigma and discrimination.
Combating prevention fatigue
The need for a non-judgmental harm reduction approach 
to the prevention of sexual transmission of HIV
"Prevention fatigue" is said to pose a threat to the acceler-
ation and sustainability of HIV prevention efforts. How-
ever, the prevention discourse is often pitched in "all or
nothing" terms, while the concept of progressive risk
reduction has not been sufficiently applied. Renewing the
discourse on safer sex and adopting approaches that are
tailored to the needs of individuals and communities
might help to boost flagging programmes.
"Prevention fatigue" has been raised as an issue for the gay
community in most industrialised countries [11]. In
France, repeated cross-sectional studies carried out among
readers of the gay press have documented increases in the
rate of unprotected anal intercourse, from 20% in the
nineties to 33% in 2007 [12]. Similar relapses in risk
behaviour have been observed in other countries [13,14].
The gay community has been widely criticized for insuffi-
cient action and continued high levels of unsafe sex. How-
ever, a national survey of sexual behaviour carried out in
France between October 2005 and March 2006 among
more than 12,000 individuals, shows that men who have
sex with men (MSM) have more condom use experience
than heterosexual populations [15]. In this study, the pro-
portion of people who reported condom use in the last
year is higher among MSM than among men who have sex
with women (MSW), especially in stable relationships
(93% of MSM vs. 81% of MSW with three partners or
more in the previous year used condoms, and 53% of
MSM vs. 17% of MSW with one partner only in the last
year used condoms). This suggests that MSM may achieve
equal or higher comfort levels with condoms than hetero-
sexual populations.
Instead of dwelling on the times when so many members
of the gay community died from AIDS related illnesses,
despite widespread community action and considerable
changes in sexual behaviour, it would be more construc-
tive to work at reaching out to, and developing pragmatic
solutions for those who, for one reason or another, do not
consistently practice safe sex.
Understanding the conditions of risk and how people
interpret risk is of key importance when designing appro-
priate HIV prevention strategies [16,17]. For many people,
HIV risk forms part of the fabric of their life. Take the
woman who is afraid to ask her husband to use a condom
because he might beat her, the young gay man who is
learning to enjoy his sexuality and struggling to manage
new sexual relationships, or the sex worker who has to
deal with clients who refuse to use condoms. These are
real life situations in which systematic condom use is just
not happening. The issue is how to manage risk in ways
that minimize the impact of risky exposures. This is chal-
lenging in a society that refuses to accept that people take
risks and blames those who do.
A way forward is to adopt a non-judgmental harm reduc-
tion approach to the prevention of sexual transmission of
HIV. HIV prevention programmes should be designed
under the assumption that, with few exceptions, HIV-neg-
ative people do not want to get the virus; and that PLWHA
do not want to transmit the virus. Our work on the
ground shows that one of the greatest concerns of PLWHA
is ongoing HIV transmission [18]. People do care. Those
who take risks also care. Despite the lack of evidence on
the effectiveness of this approach, some women use other
barrier methods, such as diaphragms, when they cannot
use male or female condoms, in the hope of reducing their
risk of HIV infection, because these methods are under
their control and undetectable by their sexual partner
[19].
Among HIV-positive MSM, serosorting is frequently
observed [14]. Although it is not demonstrated to be effec-
tive for protecting HIV-negative individuals, some indi-
viduals already living with HIV are choosing this
approach with the goal of unprotected intercourse. MSM
have also been observed to adapt their sexual practices
through strategic positioning [20]. Among networks of
gay men who otherwise seek unprotected intercourse,
condoms may be used in the event of sexually transmitted
infections [21]. Of course, the effectiveness of these strat-
egies in reducing HIV risk is uncertain. The point is that
people who have difficulties with condom use do care atJournal of the International AIDS Society 2008, 11:5 http://www.jiasociety.org/content/11/1/5
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some level about HIV risk, or else they would not bother
to use alternative strategies to reduce this risk.
There is some urgency to move beyond the "all or noth-
ing" approach to preventing sexual transmission of HIV –
as we have for the prevention of transmission of HIV
through drug use- and renew the discourse about safer sex.
Partner reduction and condom use already represent
harm reduction approaches to dealing with risky sexual
behaviours. Further multidisciplinary research is required
to assess additional risk reduction strategies, including
those observed on the ground.
The control of HIV viral load: a new approach to sexual 
risk reduction?
The reduction of maternal viral load is the mainstay of
efforts to prevent perinatal HIV transmission [22]. Viral
load suppression has also been proposed as a strategy to
reduce sexual transmission, in recognition of the strong
association between viral load and risk of transmission.
Early studies conducted in Rakai, Tanzania, among sero-
discordant heterosexual couples before the antiretroviral
era indicated that the HIV transmission rate is almost lin-
early associated with viral RNA levels in the plasma [23].
The advent of antiretroviral treatment (ART) spurred
efforts to determine the impact of viral load suppression
on HIV transmission.
Cohorts of sero-discordant couples have been observed
throughout the ART era, and although the results are still
sparse, they show that ART-induced viral load suppression
is associated with reduced levels of HIV transmission [24].
In a Spanish cohort of serodiscordant couples, HIV trans-
mission was reduced by 80% after introduction of higly
active ART (HAART). In this study, transmission never
occurred when virological suppression was achieved in
the positive partner [25].
At the end of 2007, a statement issued by Swiss experts
became the subject of much controversy [26]. Based on a
review of Vernazza [27], the authors concluded that con-
dom use may not be necessary in stable heterosexual sero-
discordant couples in which virological suppression had
been achieved in the positive partner for at least six
months. Many concerns have been raised about this posi-
tion. It has been pointed out that virological suppression
in the blood is not necessarily associated with suppression
in the genital fluids [28]. In addition, the data refer to sta-
ble heterosexual couples with no intercurrent sexually
transmitted infection, which might lead to peaks in viral
load. Despite these limitations, the results of the Swiss
study may hold promise for sero-discordant couples, the
population in which much transmission occurs in high
prevalence countries [29]. It is not, however, clear how
these results might apply to other populations at risk of
HIV. ART may therefore be retained as a useful additional
risk reduction strategy at the individual level, but more
research is needed to determine its contribution to "com-
bination prevention" within public health programmes.
The Swiss controversy gives prominence to the uneasy
question of "when to start ART". The prospects of treating
HIV-positive people for public health purposes, and not
only to achieve benefits at an individual level, raises many
complex issues. It is still an open question whether
increasing the 200 CD4 threshold point globally recom-
mended for initiating ART to the level recommended in
most industrialized countries [30] would have an impact
on HIV incidence. Recent modeling results provide a com-
pelling argument that increasing ART use could lead to a
dramatic reduction of HIV incidence, even when consid-
ering an increase in risky behavior [31]. This remains a
priority area for further research.
The impact of ART on condom use
Interestingly, in two separate studies, one conducted in
Côte d'Ivoire [32], the other in Cameroon [33], we were
able to demonstrate an independent positive effect of ART
on the systematic use of condoms. In multivariate analy-
sis, the odds ratio of systematic condom use was around
twice as high among sexually active treated PLWHA than
among untreated PLWHA. Such a result can probably be
explained by the comprehensive care and support services
provided to persons who are under treatment. In another
study conducted in Kenya, PLWHA receiving ART were
more likely to adopt safer behaviours than those not on
treatment [34].
The need for comprehensive services for PLWHA, including 
positive prevention
These data on the role of viral load on HIV transmission
and behaviour change among PLWHA suggest that
untreated PLWHA are more likely to transmit the virus,
and underline the urgent need to reach this population
with comprehensive prevention, care and support serv-
ices. In all settings, PLWHA, while in good health, are of
limited interest to health care workers, as they are not eli-
gible for treatment, and, as a result, they tend to receive
only limited psychosocial support services, if any at all.
These services are critical to support safer sex practices.
Treatment adherence support programmes have already
been introduced in several settings and have been shown
to be effective in promoting adherence when they are
focused not only on treatment but also on the person and
on all aspects of daily life [35].
For instance, Spire and others recently reported the results
of a comprehensive programme for PLWHA in Phnom-
Penh that was highly effective on treatment adherence.
95% of participants were fully adherent after two years ofJournal of the International AIDS Society 2008, 11:5 http://www.jiasociety.org/content/11/1/5
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treatment [36]. Similar approaches could be helpful in
designing behavioural interventions for individuals living
with HIV, but not yet requiring treatment, which would
empower them to adopt and maintain safer behaviours.
For PLWHA under treatment, all interventions that main-
tain long-term virological success are likely to reduce HIV
transmission risk. However, to achieve this, a comprehen-
sive approach that integrates all essential prevention, care
and support services is required, to make the most of
potential synergies. Several results obtained through
multidisciplinary studies in France and Italy suggest that
perception of treatment toxicity is a significant factor
influencing adherence [37-39] as well as sexual risk
behaviour [40,41]. The more side-effects PLWHA experi-
ence, the less adherent they are, and the less likely they are
to use condoms systematically. This in turn negatively
influences their quality of life [42]. Taking into account
the patient's reported clinical outcomes could help when
designing the best strategies to reduce viral load and risk
behaviours.
This positive relationship between perception of health
and consistent condom use has been confirmed in other
studies, conducted among a cohort of PLWHA infected
through drug use in France [43] and among PLWHA
enrolled in the Agence nationale de recherches sur le sida
et les hépatites virales (ANRS) Trivacan trial in Côte
d'Ivoire [44]. In these two distinct populations, the same
relationship between the capacity to consistently use con-
doms and the lack of perceived side-effects associated
with ART was observed.
Diversifying HIV testing approaches
Shortening the duration of the "unknown infection" period
Shortening the duration of the "unknown infection"
period should have an impact on HIV transmission. There
are many benefits of an early diagnosis, in terms of life
expectancy, but also quality of life [45]. From a public
health point of view, increasing the proportion of PLWHA
who know their status will also have a positive impact
since those who know they are infected are more likely to
adopt safer behaviours.
A meta-analysis indicated that the prevalence of unpro-
tected intercourse was reduced by 53% in positive HIV
persons in the USA who were aware of their status relative
to those who were unaware [46]. There was a 68% reduc-
tion after adjusting the data of the primary studies to focus
on unprotected intercourse with partners who were not
already infected. In rural Zimbabwe, women who tested
positive subsequently reported increased consistent con-
dom use in their regular partnerships [47]. However, in
many settings, HIV diagnoses occurs late, with negative
consequences at both individual and public health levels.
Diversifying and combining HIV testing approaches
In order to enable more people to learn their serostatus
and to open access to HIV services to those in need, a
range of HIV testing approaches need to be developed and
implemented. Stigma, fear of receiving a HIV-positive sta-
tus, lack of confidentiality, and long distances to dedi-
cated HIV testing sites may represent barriers to the
conventional voluntary counselling and testing approach.
Provider-initiated HIV testing with an opt-out option has
been widely debated for the last few years [48]. Data from
high prevalence countries indicate that this approach to
HIV testing in health care settings leads to significantly
higher rates of detection of HIV infection and disease [49].
Alternative voluntary counselling and testing service
delivery models, such as outreach through mobile vans,
can also increase access to and uptake of testing [50]. In
Morocco, a low HIV prevalence country, the community-
based NGO Association de lutte contre le sida (ALCS) has
been implementing for several years mobile testing strate-
gies, and has found that these are more effective in reach-
ing HIV-infected individuals than institutional voluntary
counselling and testing approaches [51].
The added public health value of community HIV testing
approaches needs to be further explored. Non-invasive
methods based on rapid antibody assays can be readily
carried out by non health-care professionals, and HIV
screening services based on rapid HIV testing performed
by community members has the potential to reach mar-
ginalized populations that are not otherwise served. In
addition, the combination of peer-based counselling and
rapid testing could represent an interesting preventive
strategy for highly exposed individuals who need repeated
HIV tests but who have difficulty in availing of health-
facility based voluntary counselling and testing services.
Repeated testing may be useful to reach individuals dur-
ing the period of primary HIV infection when risk of
ongoing transmission is particularly high, due to sharply
elevated viral load [52]. The role of primary infection in
the epidemic dynamics was highlighted last year in a
Canadian study. Phylogenetic analyses suggested that
early infection accounted for approximately half of
onward transmissions over a period of about a year in the
city of Montreal [53]. These data suggest that sero-igno-
rance during the early stages of the disease may make a
significant contribution to ongoing transmission.
Strategies to increase access to HIV testing should not only
facilitate entry into the health system and support com-
munity-based approaches, but should also make provi-
sion for repeat tests, especially for people who live with
risk. The earlier people know about their infection, the
less likely they are to transmit the virus.Journal of the International AIDS Society 2008, 11:5 http://www.jiasociety.org/content/11/1/5
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Dealing with stigma and discrimination
Stigma and discrimination fuel the epidemic
There is growing evidence that stigma and discrimination
contribute to risky behaviours in both HIV positive and
HIV negative individuals. In several parts of the world, the
fear of stigma and discrimination is associated with lower
uptake of HIV testing and less willingness to disclose pos-
itive results [54]. Recent data from the French ANRS
VESPA study based on a large representative sample of
PLWHA shows that perceived stigma is associated with
risky health behaviours such as non-adherence [55] and
unprotected sex [56]. More specifically a relationship
between inconsistent condom use and experience of dis-
crimination was found among heterosexuals and injecting
drug users. Multivariate analysis shows that discrimina-
tion from one's closest friends and relatives was an inde-
pendent factor associated with non- systematic use of
condoms.
Another problem is the double stigma that affects some
groups, such as injecting drug users, sex workers and men
who have sex with men. These groups already face a
higher risk of HIV infection, associated with specific
behaviours and practices, for which they are blamed. In
addition, they are ostracized independently of HIV infec-
tion. This double stigma probably contributes to the high
HIV burden in these groups, as stigma and fear of stigma
significantly constrain access to information and to serv-
ices. Yet, these groups are in greatest need of comprehen-
sive HIV prevention, care and treatment services. Many
studies have compared HIV prevalence among MSM with
prevalence in the general population. In most countries of
the world, HIV prevalence is consistently higher among
MSM. Odds ratios for HIV infection in MSM are elevated
across prevalence levels by country and decrease as gen-
eral population prevalence increases, but remain 9-fold
higher in medium-high prevalence settings [57]. Similar
findings are reported among sex workers and drug users,
who are consistently found to have much higher preva-
lence rates than other segments of the population.
A triple therapy against stigma and discrimination
We propose an effective "triple therapy" approach to fight
against stigma and discrimination. The proposed regimen
would include the following: first, fight for greater accept-
ance of PLWHA; second, improve relevant laws and poli-
cies, and third, involve prevention users – work with people
rather than for people.
Greater acceptance of HIV in our society would help peo-
ple break the secret and help them to disclose their status
without fear. The experience of AIDES in France and also
of several of its African partners, is that strengthening the
social positions of PLWHA reinforces the collective ability
to talk about HIV. It also induces changes in the way soci-
ety regards PLWHA. Of course, the ability to talk is associ-
ated with the ability to listen, which underlines the
importance of public action, based for instance on cam-
paigns featuring personalities and opinion leaders. The
use of political leaders in such campaigns is also of inter-
est; such as those used in France during the 2007 presiden-
tial election [58]. The goal of these campaigns, which have
been very popular, is to make people reflect on how HIV
status impacts attitudes. Associated with other measures,
such as public testimonies of PLWHA, and meaningful
engagement of PLWHA in the design, implementation
and evaluation of HIV programmes, they can contribute
to changing the representation of HIV in the general pub-
lic.
The improvement of laws and policies should serve to
protect PLWHA and all vulnerable groups. Prevailing iniq-
uitous measures undermine the response to AIDS. Laws
which discriminate against or criminalize drug users, men
who have sex with men, sex workers, and immigrants are
likely to compromise their access to, and utilization of
HIV prevention, care and treatment services, which in turn
is likely to contribute to the spread of the epidemic. It is
encouraging that some Latin American countries have
launched policies and programs focused on reducing
homophobia. Such measures urgently need to be intro-
duced in other settings, particularly in Africa where com-
munity-based HIV prevention work can be dangerous for
both the service providers and clients. This is exemplified
by the recent arrest of gay prevention activists in some
African countries. Similarly, the repression of drug users
in several countries runs counter to public health inter-
ests. Changes will only be possible if international institu-
tions, especially financial backers, step up pressure on
governments to guarantee a rights-based approach to pub-
lic health. Changes will also be brought about by involv-
ing communities affected by HIV in the process of
decision making.
Community mobilization among PLWHA has been
shown to be a driving force in increasing access to treat-
ment. To improve HIV prevention efforts, HIV-positive
people, those who are most exposed to infection and
affected communities need to mobilize together. There
must be a real effort to ensure that those living with HIV
are truly involved by occupying key positions in non gov-
ernmental organizations. The mobilization of people who
are "sero-concerned" is essential as the professional
response will never be sufficient.
For the last 25 years, HIV prevention uptake has improved
through community mobilization and peer support, lead-
ing to the empowerment of those who are marginalized
and most at risk [59]. People who are only "experts based
on their life experience" [60] have run prevention pro-Journal of the International AIDS Society 2008, 11:5 http://www.jiasociety.org/content/11/1/5
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grammes for gay men, conceptualized harm reduction
approaches for drug users, and reached out with HIV pre-
vention services to marginalized groups such as migrant
women.
The mobilization of sex workers all over the world has led
to successes in prevention programmes. The Sonagachi
project in India, run by and for sex workers, has resulted
in impressive coverage rates with HIV and other services
for sex workers in the state of West Bengal and HIV preva-
lence rates have remained low in these communities [61].
In Santo Domingo, interventions combining support for
sex worker solidarity and changes in government policy
are showing positive effects. In Paris, the PAST project has
mobilized sex workers and transgenders to claim their
rights and obtain services.
Finally, a breakthrough in the field of community mobili-
zation is the emergence of gay men in an African context.
Until recently MSM were not counted and ignored by Afri-
can and international policy-makers. AIDES has recently
supported the mobilization of gay Africans, and has
found that MSM are not so few, they are visible, they want
to contribute to the public health policies and can become
community health actors despite homophobic environ-
ments [62].
The way forward: investing in community 
mobilization
HIV prevention can work when it reflects the comprehen-
sive needs of people. Our experience with community
mobilization in concentrated epidemics is that it is an
essential component of the response. In generalized epi-
demics, more research and experience are needed to
understand how to mobilize those most at risk. Nonethe-
less, the empowerment of communities remains a global
imperative and challenge. It requires real empowerment
of PLWHA as well as the empowerment of marginalized
and stigmatized populations. The key message is to
involve lay-men and women in public health action.
With this aim, four non-governmental organizations that
privilege community involvement and recognize acquired
expertise have decided to create a new international struc-
ture called PLUS. Its goal is to enable the voices of sero-
concerned people to reach and influence international
policy makers, by enhancing the global visibility of com-
munity commitment in the fight against AIDS and pro-
moting community-based research.
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